Schedule 13D
This Amendment No. 5 (“Amendment”) amends and supplements the Schedule 13D filed with the SEC on October 31, 2014, as previously amended by the Schedule 13D/A filed with the SEC on September 2, 2015, as previously amended by the Schedule 13D/A filed with the SEC on March 21, 2016, as previously amended by the Schedule 13D/A filed with the SEC on June 8, 2016, and as previously amended by the Schedule 13D/A filed with the SEC on January 12, 2018 (the “Schedule 13D”). Except as set forth in this Amendment, the Schedule 13D remains unchanged. Unless otherwise indicated, all capitalized terms used herein but not defined herein shall have the same meaning as set forth in the Schedule 13D.
The following items of this Schedule 13D are hereby amended as follows.
ITEM 4. PURPOSE OF TRANSACTION
The Filers hereby add the following disclosure to this Item 4:
The Filers and the Issuer are party to a Nomination Agreement dated March 17, 2016 (the “Nomination Agreement”). Under the Nomination Agreement, so long as the Filers and their affiliates beneficially own more than 10% of the Issuer’s outstanding common shares, the Filers are entitled to nominate a director to the Issuer’s Board of Directors. At the Issuer’s Annual Meeting of Shareholders held on April 29, 2020, Eileen Wheatman was elected to the Issuer’s Board of Directors in connection with the Nomination Agreement. Rodney (Rod) Nunn, who previously served as a director of the Issuer in connection with the Nomination Agreement ceased to be a director of the Issuer at the Issuer’s Annual Meeting of Shareholders held on April 29, 2020. The foregoing summary of the principal terms of the Nomination Agreement does not purport to be complete and is qualified in its entirety by reference to the full copy of the Nomination Agreement, filed as Exhibit 7.5 to the Filer’s Amendment No. 2 to Schedule 13D filed with the SEC on March 21, 2016, and incorporated by reference herein.
The Filers may participate in and influence the affairs of the Issuer through their rights under the Nomination Agreement. No additional consideration was paid by or to the Issuer, or the Filers in connection with the election of Ms. Wheatman to the Issuer’s Board of Directors in connection with the Nomination Agreement, and therefore no funds were used in connection with the transactions requiring the filing of this statement.
The Filers do not have any present plan or proposal that would relate to or result in any of the matters set forth in subparagraphs (a) – (j) of Item 4 of Schedule 13D, except as set forth herein or such as would occur upon completion of any of the actions discussed herein.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) and (b) The beneficial ownership of the Common Stock by each Filer at the date hereof is reflected on that Filer’s cover page.
(c) There were no transactions effected by the Filers in the Common Stock within the past sixty (60) days.